Athira Raveendran is currently an Integrated Ph.D. student at the Chonnam National University. 
Her Ph.D. research focuses on designing and developing fluorescent dye-based drugs and tumor-targeting delivery systems for anticancer therapy. Our approach is to target cancer cells exclusively with the conjugates of fluorescent dyes and cell-penetrating peptides, without harming healthy tissues. Also focusing on determining the cell signaling pathways and mechanism of cell death.
 
 

Publications

​

Athira Raveendran‡, Suchithra Poilil Surendran‡, Jinhui Ser, Khurshed Alam, Hoonsung Cho*, Yong Yeon Jeong*. Heptamethine cyanine dye MHI-148-mediated drug delivery system to enhance the anti-cancer efficiency of paclitaxel. Int J Nanomedicine. 2021; 16: 7169-7180 (IF 7.03, JCR 11%)

​

Khalid Usman‡, Doori Kang‡, Geonwoo Jeong, Khurshed Alam, Athira Raveendran, Jinhui Ser, Woohyung Jang, Hoonsung Cho, The Surface Properties of Implant Materials by Deposition of High-Entropy Alloys (HEAs), Nanomaterials, 2023, 1, 6 (IF 5.719, JCR Q1)

​

Working on

​

Jinhui Ser‡, Geonwoo Jeong‡, Athira Raveendran, Hoonsung Cho*. The novel Peptide-based Anticancer strategies with self-fluorescence Riboflavin. ~ Writing manuscript

​

Jinhui Ser‡, Athira Raveendran‡, Geonwoo Jeong, Hoonsung Cho*. Development of lysosome-induced anticancer agent using Dual-Peptide with Cyanine dye. ~ Writing manuscript

​

Athira Raveendran‡, Jinhui Ser‡, Hoonsung Cho*. The conjugation of Protamine with ZW-800 for cancer treatment. ~ Writing manuscript

​

Book chapter

​

Jinhui Ser‡, Athira Raveendran‡, Uk Sim, Hoonsung Cho, Chapter 10: Nanobioreactors and nanobioprocessing nanobioelectrocatalysis in biosensors and biofuel cells, Nanomaterials for Bioreactors and Bioprocessing Applications, Elsevier, 2023, 1

​